Stevan A. Gonzalez

Vantage Point Transplantation

An in-depth look at a unique patient subset.

Vantage Point: Transplantation

Treatment of HCV Following Liver Transplantation in the Era of Direct-Acting Antivirals

HCV Next, December
Stevan A Gonzalez, MD, MS
Chronic infection with hepatitis C virus remains the leading indication for liver transplantation in the United States. As the prevalence of…
Vantage Point: Transplantation

Antiviral Therapy for HCV in Liver Transplant Candidates

HCV Next, March/April
Steven A. Gonzalez, MD, MS
The emergence of direct-acting antiviral therapy has transformed the management of chronic hepatitis C virus infection. The availability of…